Skip to main content
. 2021 Mar 9;6(1):51–57. doi: 10.1016/j.ncrna.2021.03.001

Table 2.

Differentially expressed microRNA-210 target genes in severe and mild preeclampsia plasma samples versus controls.

Gene Symbol Mild PE
Fold change
P ˂ 0.01* Severe PE
Fold change
P ˂ 0.01*
ACVR1B NA NA 0.283 0.0094
ADAM-17 NA NA 0.089 0.0084
AIFM3 0.421 0.0054 0.378 0.0042
CDKN1C 0.144 0.0034 0.100 0.0076
CASP8AP2 0.445 0.0069 0.345 0.0091
COX10 0.097 0.0053 −1.44 0.0071
E2F3 0.065 0.0042 −1.10 0.0095
EFNA1 0.356 0.0036 0.111 0.0081
EFNA3 0.094 0.0065 −1.02 0.0091
FOXA1 0.466 0.0063 0.236 0.0072
HOXA1 0.064 0.0025 −1.08 0.0079
HOXA9 −1.12 0.0075 −1.94 0.0027
ISCU −1.86 0.0093 −2.54 0.0052
KCMF1 −1.54 0.0034 −2.44 0.0054
NR4A2 −1.99 0.0068 −2.99 0.0019
PTPN2 −1.05 0.0039 −1.64 0.0062
RAD52 −1.45 0.0025 −2.12 0.0047
THSD7A −2.24 0.0017 −3.43 0.0053

*P value is for fold change observed for each gene amplified. A conservative selection criterion (fold change ˂ 0.5 and p value ˂ 0.01) was considered.

NA: Not Applicable.